Conversely, sleep fragmentation or deprivation (9, 70, 71) and increased nocturnal activity (72, 73) — both risk factors for, and observed in, AD — may prevent the nocturnal BT drop (12), increasing tau secretion and potentially accelerating tau pathogenesis (74, 75). This evidence concerns the gene MAPT and Alzheimer disease.